Home › Funds › Paralel Advisors LLC › AMRX

Paralel Advisors LLC position in AMRX

AMNEAL PHARMACEUTICALS INC · Health Care

Paralel Advisors LLC reported holding 187,941 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 0.15% of its reported portfolio and ranking #30 among its reported holdings. Paralel Advisors LLC has disclosed AMRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)187.94K sh
Reported value held$3.79M
Portfolio Weight0.15%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Paralel Advisors LLC's AMRX position evolved

Paralel Advisors LLC first disclosed a stake in AMRX in Q2 2026 at 185,831 shares (US$3.2M). The position peaked in Q3 2026 at 187,941 shares, worth US$3.8M. Across 2 filings, Paralel Advisors LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 187,941 shares valued at US$3.8M — an increase of 2,110 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 185.83K $3.22M New
Q3 2026 187.94K $3.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMRX and 13F data

AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$39.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMRX

All AMRX fund holders →

FAQ

How long has Paralel Advisors LLC held AMRX?

Paralel Advisors LLC has disclosed AMRX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Paralel Advisors LLC's current position in AMRX?

As of Q3 2026, Paralel Advisors LLC holds 187.94K shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $3.79M, representing 0.15% of its reported portfolio and ranking #30.

Has Paralel Advisors LLC been buying or selling AMRX?

In the latest 13F filing (Q3 2026), Paralel Advisors LLC increased its position in AMRX. The position peaked in Q3 2026 at 187.94K shares.

Which other funds hold AMRX?

Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.